Mei-Yun Zhang

发表

Structure of a V3-Containing HIV-1 gp120 Core

Bette Korber, Peter D. Kwong, Robyn L. Stanfield, 2005, Science.

Structural definition of a conserved neutralization epitope on HIV-1 gp120

Tongqing Zhou, Gary J. Nabel, Peter D. Kwong, 2007, Nature.

Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".

Y. Shao, Mei-Yun Zhang, Zehua Sun, 2015, Antiviral research.

The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development

Zhiwei Chen, Y. Shao, Jianqing Xu, 2013, AIDS.

Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp120 and gp41

D. Dimitrov, Yuxing Li, Richard Wilson, 2012, PloS one.

Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp 120 and gp

D. Dimitrov, Yuxing Li, Richard Wilson, 2012 .

Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: differences from the human counterparts and implications for HIV-1 vaccine development.

D. Dimitrov, Yanping Wang, E. Streaker, 2011, Vaccine.

A single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to HIV-1 envelope glycoproteins

Mei-Yun Zhang, Jingjing Li, T. Yuan, 2011, mAbs.

Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1

R. Ptak, B. Haynes, D. Dimitrov, 2010, mAbs.

Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.

D. Dimitrov, J. Gan, P. Prabakaran, 2006, Journal of molecular biology.

Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.

D. Burton, D. Dimitrov, X. Ji, 2004, Biochemistry.

Conformational and structural features of HIV-1 gp120 underlying the dual receptor antagonism by cross-reactive neutralizing antibody m18.

D. Dimitrov, J. Gershoni, E. Freire, 2011, Biochemistry.

Sequential antigen panning for selection of broadly cross-reactive HIV-1-neutralizing human monoclonal antibodies.

D. Dimitrov, Mei-Yun Zhang, 2009, Methods in molecular biology.

Monoclonal antibody m18 paratope leading to dual receptor antagonism of HIV-1 gp120.

D. Dimitrov, I. Chaiken, Mei-Yun Zhang, 2011, Biochemistry.

Potent Neutralization of Hendra and Nipah Viruses by Human Monoclonal Antibodies

Lin-Fa Wang, Yang Feng, C. Broder, 2006, Journal of Virology.

Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration.

D. Dimitrov, I. Sidorov, Mei-Yun Zhang, 2006, Biochemical and biophysical research communications.

Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS.

D. Dimitrov, Xiaodong Xiao, Mei-Yun Zhang, 2005, Current opinion in molecular therapeutics.

Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogen.

R. Ptak, D. Dimitrov, Yanping Wang, 2009, Vaccine.

Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins

D. Hamer, D. Dimitrov, James E. Robinson, 2016, Journal of Virology.

Competitive antigen panning for selection of HIV-1 neutralizing human monoclonal antibodies specific for gp41.

D. Dimitrov, Mei-Yun Zhang, 2009, Methods in molecular biology.

Isolation and characterization of an HIV-1 envelope glycoprotein-specific B-cell from an immortalized human naïve B-cell library.

Mei-Yun Zhang, Zehua Sun, Shiqiang Lu, 2017, The Journal of general virology.

Antibody-Based Resistance to Plant Pathogens

S. Schillberg, R. Fischer, S. Zimmermann, 2004, Transgenic Research.

Characterization of a chimeric monoclonal antibody against the insulin-like growth factor-I receptor

D. Dimitrov, Yanping Wang, Yang Feng, 2009, mAbs.

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.

David C Montefiori, Susan Zolla-Pazner, Nelson L Michael, 2008, Virology.

Novel approaches for identification of broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies and improvement of their potency.

D. Dimitrov, Mei-Yun Zhang, 2007, Current pharmaceutical design.

Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120

Tongqing Zhou, Gary J. Nabel, Peter D. Kwong, 2009, Science.

Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.

S. Rybak, C. Broder, J. Louis, 2007, Virology.

Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning.

C. Broder, H. Katinger, D. Dimitrov, 2006, Journal of immunological methods.

Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity

Mei-Yun Zhang, Zehua Sun, Xi Liu, 2018, Front. Immunol..

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.

Wayne A Hendrickson, Peter D Kwong, Joseph Sodroski, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Function-based high-throughput screening for antibody antagonists and agonists against G protein-coupled receptors

Liaoyuan A. Hu, Yingli Ma, Jian Li, 2020, Communications Biology.

Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens

D. Dimitrov, N. Longo, P. Prabakaran, 2009, Biochemical and Biophysical Research Communications.

Identiﬁcation and Characterization of a New Cross-Reactive Human Immunodeﬁciency Virus Type 1-Neutralizing Human Monoclonal Antibody

Dennis R. Burton, Xiaodong Xiao, Peter Bouma, 2022 .

Function-based high-throughput screening for antibody antagonists and agonists against G protein-coupled receptors

Liaoyuan A. Hu, Yingli Ma, Jian Li, 2020, Communications Biology.

Identification of Dominant Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Antigen of Pandemic H1N1 Influenza Virus

I. Hung, Jianqing Xu, Mei-Yun Zhang, 2013, Journal of Virology.

Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning.

D. Dimitrov, P. Prabakaran, R. Lal, 2004, Journal of molecular biology.

UvA-DARE ( Digital Academic Repository ) Neutralizing antibodies to the HIV-1 envelope glycoproteins

C. Broder, J. Binley, D. Burton, 2009 .

Cross-Reactive Human Immunodeficiency Virus Type 1-Neutralizing Human Monoclonal Antibody That Recognizes a Novel Conformational Epitope on gp41 and Lacks Reactivity against Self-Antigens

B. Haynes, M. Humbert, C. Broder, 2008, Journal of Virology.

Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 Antibodies

D. Dimitrov, Jianqing Xu, Mei-Yun Zhang, 2015, PloS one.

Title Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins : Implications for evasion of immune responses and design of vaccine

D. Dimitrov, N. Longo, P. Prabakaran, 2009 .

Antibody-based inhibitors of HIV infection

D. Dimitrov, P. Prabakaran, Mei-Yun Zhang, 2006, Expert opinion on biological therapy.

Construction of a recombinant full-length membrane associated IgG library.

Mei-Yun Zhang, Zehua Sun, Shiqiang Lu, 2017, Virus research.

Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library.

S. Rybak, C. Broder, D. Dimitrov, 2003, Journal of immunological methods.

Symbiotic Nitrogen Fixation in the Fungus Gardens of Leaf-Cutter Ants

David M. Stevenson, Paul J. Weimer, Cameron R. Currie, 2009, Science.

All known cross-reactive HIV-1 neutralizing antibodies are highly divergent from germline and their elicitation may require prolonged periods of time

B. Haynes, D. Dimitrov, M. Markowitz, 2008 .

Neutralizing antibodies to the HIV-1 envelope glycoproteins

C. Broder, J. Binley, D. Burton, 2004 .

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.

S. Zolla-Pazner, D. Dimitrov, D. Montefiori, 2008, Virology.

Novel Hiv Neutralizing Antibodies Selected from Phage Display Libraries

D. Dimitrov, Mei-Yun Zhang, M. Moulard, 2004 .

Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: differences from the human counterparts and implications for HIV-1 vaccine development.

D. Dimitrov, Yanping Wang, E. Streaker, 2011, Vaccine.

Germline-like predecessors of antibodies Implications for evasion of immune responses and design of vaccine immunogens

D. Dimitrov, N. Longo, P. Prabakaran, 2009 .